1. Russian Pharmaceutical Market 2012 15 April 2013 Shulyak Sergey General Director DSM Group

2. The result of 2012 year Source: DSM Group, audit of pharmaceutical market RF

3. The result of 2012 year: units Source: DSM Group, audit of pharmaceutical market RF

4. Per capita consumption of medicines in Russia (pharma market) Source: DSM Group, audit of pharmaceutical market RF

5. Retail segment is 74% Russian pharma market Source: DSM Group, audit of pharmaceutical market RF

6. Retail segment in recent years, growing much faster Source: DSM Group, audit of pharmaceutical market RF

7. Turnover of drags market is positive in EURO Source: DSM Group, audit of pharmaceutical market RF

8. The largest contribution to the growth of pharma market - structural change in favor of expensive drugs Source: DSM Group, audit of pharmaceutical market RF

9. Retail drug market capacity in Russia and other countries in 2012 Retail drug market = retail segment + reimbursement program Source: DSM Group, audit of pharmaceutical market RF, open sources

10. Retail drug market capacity in Russia and other countries in 2012 Retail drug market = retail segment + reimbursement program Source: DSM Group, audit of pharmaceutical market RF, open sources

11. Per capita consumption of medicines in the world (retail drug market) Retail drug market = retail segment + reimbursement program Source: DSM Group, audit of pharmaceutical market RF, open sources

12. Rating of drug manufacturing companies: TOP 20 – 52,5% Source: DSM Group, audit of pharmaceutical market RF

13. Rating of ATC classification Source: DSM Group, audit of pharmaceutical market RF

14. Quantity of drugs in the Russian pharma market Source: DSM Group, audit of pharmaceutical market RF

15. www.dsm.ru JSC DSM Group Yamskogo Polya St. 7/2 Moscow, 125040 Russia Contacts: Sergey Shulyak sshulyak@dsm.russhulyak@dsm.ru Lilit Kotsinyan lkotsinyan@dsm.ru